GemVax&KAEL Co.,Ltd.

A082270

KR7082270000

Semiconductors

End-of-day quote Korea S.E. Other stock markets 03:30:00 16/05/2024 am IST			5-day change	1st Jan Change
11,670 ^KRW	-0.51%		-2.75%	-12.12%

02/05	Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	CI
25/03	GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	CI

GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.

April 13, 2022

The Board of Directors of GemVax&KAEL Co.,Ltd has authorized a buyback plan on April 13, 2022.

Latest news about GemVax&KAEL Co.,Ltd.

Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	02/05	CI
GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	25/03	CI
GemVax&KAEL Co.,Ltd. announced that it expects to receive KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	21/03	CI
Gemvaxlink Co., Ltd. announced that it has received KRW 29.099978456 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd and other investors	18/03	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on June 14, 2022.	31/22/31	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 150,000 shares.	14/22/14	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	14/22/14	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on April 13, 2022.	13/22/13	CI
GemVax&KAEL Co.,Ltd's Equity Buyback announced on April 13, 2022, has closed with 300,000 shares, representing 0.76% for KRW 4,333.75 million.	10/22/10	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 300,000 shares.	13/22/13	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	13/22/13	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) added to S&P Global BMI Index	20/21/20	CI
GemVax&KAEL Co.,Ltd acquired additional 12.9% stake in Gemvaxlink Co., Ltd. for KRW 18 billion.	19/21/19	CI
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion.	19/21/19	CI
GemVax's Highly Promising Phase II Alzheimer's Disease Clinical Trial Results Targeting Telomerase Published in Alzheimer's Research & Therapy' Journal	30/21/30	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) dropped from S&P Global BMI Index	22/21/22	CI
GemVax & KAEL Announces the Decision to Apply for an Expanded Access IND for Its Lead Candidate GV1001 to Include Additional Investigational Groups in Alzheimer's	06/20/06	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	18/20/18	CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	10/20/10	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 4.999999927 billion in funding from GemVax&KAEL Co.,Ltd	16/20/16	CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 4.999999927 billion in funding from GemVax&KAEL Co.,Ltd	08/20/08	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 8.4 billion in funding from GemVax&KAEL Co.,Ltd	30/20/30	CI
GemVax Announces Phase II Results of GV1001 for Alzheimer's Disease Treatment at CTAD 2019	11/19/11	CI
Enerzent Co., Ltd. announced that it has received KRW 10 billion in funding from GemVax&KAEL Co.,Ltd	11/19/11	CI
GemVax&KAEL Co.,Ltd announced that it has received KRW 35 billion in funding	10/18/10	CI

GemVax & KAEL Co.,Ltd is a Korea-based company mainly engaged in the manufacture of pollution control equipment used in semiconductor manufacturing processes. The Company and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The Company distributes its products within domestic market and to overseas markets.

Sector

Semiconductors

More about the company

Income Statement Evolution

More financial data

Sector Other Semiconductors

	1st Jan change	Capi.
GEMVAX&KAEL CO.,LTD.	-12.12%	342M
NVIDIA CORPORATION	+90.51%	2,328B
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED	+41.82%	677B
BROADCOM INC.	+26.53%	666B
AMD (ADVANCED MICRO DEVICES)	+10.35%	258B
QUALCOMM, INC.	+33.60%	217B
TEXAS INSTRUMENTS INCORPORATED	+14.40%	178B
MICRON TECHNOLOGY, INC.	+49.85%	142B
INTEL CORPORATION	-36.24%	133B
ARM HOLDINGS PLC	+52.00%	118B

Other Semiconductors